Education
About Us
Working with TipRanks
Follow Us
Futura Medical PLC (GB:FUM)
LSE:FUM
FUM Stock Chart & Stats
Day’s Range― - ―
52-Week Range8.48p - 45.56p
Previous CloseN/A
Volume13.08K
Average Volume (3M)419.08K
Market Cap
£30.08M
Enterprise Value113.29M
Total Cash (Recent Filing)£4.03M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.12
Next Earnings
Sep 23, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding303,829,680
10 Day Avg. Volume407,425
30 Day Avg. Volume419,082
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.51
Price to Cash Flow (P/CF)-4.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
140.00pPrice Target Upside1352.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Futura Medical News
PremiumCompany Announcements
Futura Medical Achieves Significant Growth with Eroxon® Launches
PremiumCompany Announcements
Futura Medical to Announce 2024 Financial Results and Host Investor Webinars
PremiumCompany Announcements
Futura Medical Strengthens Board with New Appointment
PremiumCompany Announcements
Futura Medical Exceeds 2024 Expectations but Faces Challenges Ahead
PremiumCompany Announcements
Futura Medical Reports Positive Study Results for WSD4000
PremiumCompany Announcements
Futura Medical Reports Positive Outcomes for WSD4000 Study
PremiumCompany Announcements
Futura Medical Issues Shares for Non-Executive Director Remuneration---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRevenues increased to £13.9m, ahead of market expectations and up 349% vs. FY23 (£3.1m).
Product DevelopmentFutura's female sexual dysfunction product, WSD4000, has delivered positive results in a home user study, which saw the product deliver an overall positive change in sexual function after four weeks.
ProfitabilityFor the first time, profitability was also achieved (£1.3m) above expectations.
Bears Say
Market Expansion ChallengesInvestors will rightly be focused on 2025 and outlook following the trading update on Jan 30 flagging slower-than-expected initial consumer uptake in the US and slower-than-planned EU market roll-outs.
Market OutlookFutura has reiterated that it expects FY25 revenues to be approx. 50% lower than previously expected.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.65% Insiders
―
Mutual Funds
― Other Institutional Investors
99.35% Public Companies and
Individual Investors
FUM FAQ
What was Futura Medical PLC’s price range in the past 12 months?
Futura Medical PLC lowest share price was 8.48p and its highest was 45.56p in the past 12 months.
What is Futura Medical PLC’s market cap?
Futura Medical PLC’s market cap is £30.08M.
When is Futura Medical PLC’s upcoming earnings report date?
Futura Medical PLC’s upcoming earnings report date is Sep 23, 2025 which is in 160 days.
How were Futura Medical PLC’s earnings last quarter?
Futura Medical PLC released its earnings results on Apr 15, 2025. The company reported 0.001p earnings per share for the quarter, beating the consensus estimate of N/A by 0.001p.
Is Futura Medical PLC overvalued?
According to Wall Street analysts Futura Medical PLC’s price is currently Undervalued.
Does Futura Medical PLC pay dividends?
Futura Medical PLC does not currently pay dividends.
What is Futura Medical PLC’s EPS estimate?
Futura Medical PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Futura Medical PLC have?
Futura Medical PLC has 303,829,680 shares outstanding.
What happened to Futura Medical PLC’s price movement after its last earnings report?
Futura Medical PLC reported an EPS of 0.001p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5%.
Which hedge fund is a major shareholder of Futura Medical PLC?
Currently, no hedge funds are holding shares in GB:FUM
---
Futura Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
140.00p (1352.28% Upside)
140.00p (1352.28% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-72.50%
12-Months-Change
Fundamentals
Return on Equity
-47.43%
Trailing 12-Months
Asset Growth
-7.26%
Trailing 12-Months
Company Description
Futura Medical PLC
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
---
FUM Stock 12 Month Forecast
Average Price Target
140.00p
▲(1352.28% Upside)
Technical Analysis
Best Analysts Covering FUM
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-72.47%
reiterated a buy rating 2 days ago
Copying James Orsborne's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -72.47% per trade.
---